ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
노로바이러스 치료 시장 규모는 향후 수년간 급성장이 전망될 예정입니다. 이러한 성장에 기여하는 주요 요인은 항바이러스 의약품 연구에 대한 자금 지원 증가, 신속한 진단 솔루션의 채택 증가, 노로바이러스가 공중 보건 문제로 인식이 높아짐, 개발도상국의 의료 서비스 접근성 확대, 증상 심각도를 줄이기 위한 지원 치료 옵션의 발전 등입니다. 예측 기간 동안 예상되는 주요 트렌드는 백신 혁신의 진보, 새로운 항바이러스 치료법 개발, 분자 진단 기술의 향상, AI 기반 진단 시스템의 활용, 공중 보건 이니셔티브의 강화, 저렴한 현장 치료 옵션의 도입 등입니다.
감염병의 발병률이 증가함에 따라 노로바이러스 치료제 시장의 성장이 촉진될 것으로 예상됩니다. 박테리아, 바이러스, 곰팡이 또는 기생충에 의해 발생하는 이러한 질병에는 인플루엔자, 결핵, HIV/AIDS, 말라리아 및 노로바이러스가 포함되며, 사람들 사이에서 빠르게 확산될 수 있습니다. 도시의 과밀화는 인구 밀집 지역에서 병원균이 더 빠르게 전파될 수 있게 함으로써 이러한 동향에 중요한 역할을 합니다. 노로바이러스 치료는 적절한 수분 공급, 위생 및 격리 등의 관행을 통해 증상을 효과적으로 관리하고 확산을 줄임으로써 이러한 질병의 영향을 완화하는 데 도움이 됩니다. 예를 들어, 2025년 3월, 세계보건기구는 2023년에 전 세계적으로 1,080만 명이 결핵에 감염되었으며, 그 중 600만 명은 남성, 360만 명은 여성, 130만 명은 어린이라고 보고했습니다. 이러한 전염병의 부담이 증가하면서 노로바이러스 치료제 시장이 확대되고 있습니다.
노로바이러스 치료 시장의 기업들은 표적 면역화를 촉진하고, 심각한 감염에 대한 보호를 개선하며, 노로바이러스 관련 질병이 전 세계에 미치는 영향을 줄이기 위해 첨단 mRNA 백신과 같은 혁신적인 솔루션에 점점 더 집중하고 있습니다. 이러한 mRNA 백신은 공학적으로 조작된 메신저 RNA를 사용하여 세포가 특정 단백질을 생성하도록 유도하여 다양한 병원체에 대한 안정성, 효과 및 적응성이 향상된 표적 면역 반응을 유도합니다. 예를 들어, 2024년 10월, 미국에 본사를 둔 생명공학 기업인 Moderna Inc.는 영국 보건 보안청(UKHSA)과 협력하여 영국에서 세계 최초의 mRNA 노로바이러스 백신(mRNA-1403)의 3상 임상 시험을 시작했습니다. 이 백신은 살아있는 바이러스를 사용하지 않고, 신체가 강력한 면역 반응을 자극하는 바이러스 단백질을 생성하도록 유도하여 전염성이 높은 노로 바이러스를 퇴치하도록 설계되었습니다. 주요 특징으로는 내구성 향상을 위한 안정화된 mRNA의 사용, 진화하는 바이러스 균주에 대응한 신속한 개발 능력, 항체 및 T 세포 반응을 모두 유발하는 능력 등이 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 노로바이러스 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 노로바이러스 치료 시장 : 성장률 분석
세계의 노로바이러스 치료 시장 실적 : 규모와 성장(2019-2024년)
세계의 노로바이러스 치료 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 노로바이러스 치료 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 노로바이러스 치료 시장 : 치료별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
전해질
정맥내 주입
해열제
진통제
설사 억제제
기타 치료법
세계의 노로바이러스 치료 시장 : 진단별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세균 배양 검사
대변 검사
기타 진단
세계의 노로바이러스 치료 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
정맥내
피하
세계의 노로바이러스 치료 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
재택 케어 설정
세계의 노로바이러스 치료 시장 : 전해질 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구 보수염(ORS)
스포츠 음료
소아용 전해질 용액
세계의 노로바이러스 치료 시장 : 정맥내 주입 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
결정질
콜로이드
젖산 링거액
세계의 노로바이러스 치료 시장 : 해열제 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
아세트아미노펜(파라세타몰)
이부프로펜
아스피린
세계의 노로바이러스 치료 시장 : 진통제 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
비스테로이드성 항염증제(NSAID)
오피오이드 진통제
아세트아미노펜계 진통제
세계의 노로바이러스 치료 시장 : 설사 억제제 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
로페라미드
다음 살리실산 비스무트
디페녹실레이트-아트로핀
세계의 노로바이러스 치료 시장 : 기타 치료법 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제토제
프로바이오틱스
아연 보충제
제7장 지역별, 국가별 분석
세계의 노로바이러스 치료 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 노로바이러스 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
노로바이러스 치료 시장 : 경쟁 구도
노로바이러스 치료 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Johnson and Johnson : 개요, 제품 및 서비스, 전략 및 재무 분석
F. Hoffmann-La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck and Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Bayer AG
Sanofi SA
Bristol-Myers Squibb Company
Abbott Laboratories
Novartis AG
AstraZeneca plc
GSK plc
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd.
Reckitt Benckiser Group plc
Sun Pharmaceutical Industries Ltd.
Lupin Ltd.
Aurobindo Pharma Limited
Cipla Inc.
Endo International plc
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
노로바이러스 치료 시장(2029년) : 새로운 기회를 제공하는 국가
노로바이러스 치료 시장(2029년) : 새로운 기회를 제공하는 부문
노로바이러스 치료 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Norovirus treatment involves supportive care designed to alleviate symptoms like vomiting, diarrhea, and stomach pain caused by the virus. This care primarily focuses on maintaining hydration, getting adequate rest, and managing symptoms, as there is currently no specific antiviral medication available for norovirus.
Key components of norovirus treatment include electrolytes, intravenous fluids, antipyretics, analgesics, anti-diarrheal medications, and others. Electrolytes are essential minerals that carry an electric charge and play a crucial role in vital bodily functions such as nerve communication, muscle contractions, maintaining hydration, and regulating pH balance. Diagnostic approaches consist of stool tests, bacterial culture tests, and more. Routes of administration vary and include oral, intravenous, or subcutaneous methods, and these treatments are delivered across settings such as hospitals, clinics, and homecare environments.
The norovirus treatment market research report is one of a series of new reports from The Business Research Company that provides norovirus treatment market statistics, including the norovirus treatment industry global market size, regional shares, competitors with the norovirus treatment market share, detailed norovirus treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the norovirus treatment industry. This norovirus treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The norovirus treatment market size has grown rapidly in recent years. It will grow from $1.75 billion in 2024 to $1.94 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. Growth during the historical period was driven by increasing global outbreaks of norovirus, heightened public awareness, a stronger emphasis on supportive care strategies, rising investments in vaccine development, improvements in healthcare infrastructure, and increased demand for efficient infection control practices.
The norovirus treatment market size is expected to see rapid growth in the next few years. It will grow to $2.91 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. Key factors contributing to this growth include increased funding for antiviral drug research, higher uptake of rapid diagnostic solutions, greater recognition of norovirus as a public health concern, expanded healthcare access in developing regions, and advancements in supportive care options aimed at reducing symptom severity. Prominent trends anticipated during the forecast period are progress in vaccine innovation, development of new antiviral treatments, enhancements in molecular diagnostics, utilization of AI-powered diagnostic systems, stronger public health initiatives, and the introduction of affordable point-of-care therapeutic options.
The rising incidence of infectious diseases is expected to drive the growth of the norovirus treatment market. These diseases, caused by bacteria, viruses, fungi, or parasites, include influenza, tuberculosis, HIV/AIDS, malaria, and norovirus, and can spread rapidly among people. Urban overcrowding plays a significant role in this trend by enabling faster transmission of pathogens within densely populated areas. Norovirus treatment helps mitigate the impact of such diseases by effectively managing symptoms and reducing spread through practices like proper hydration, hygiene, and isolation. For example, in March 2025, the World Health Organization reported that 10.8 million people globally were infected with tuberculosis in 2023, including 6.0 million men, 3.6 million women, and 1.3 million children. This growing burden of infectious diseases is contributing to the expansion of the norovirus treatment market.
Companies in the norovirus treatment market are increasingly focusing on innovative solutions such as advanced mRNA vaccines to promote targeted immunization, improve protection against severe infections, and reduce the global impact of norovirus-related illnesses. These mRNA vaccines use engineered messenger RNA to direct cells to produce specific proteins, eliciting a targeted immune response with enhanced stability, effectiveness, and adaptability against various pathogens. For instance, in October 2024, Moderna Inc., a US-based biotechnology company, in collaboration with the UK Health Security Agency (UKHSA), initiated the world's first Phase 3 clinical trial of an mRNA norovirus vaccine (mRNA-1403) in the UK. This vaccine is designed to combat the highly contagious norovirus by prompting the body to generate viral proteins that stimulate a robust immune response, without using the live virus. Key features include the use of stabilized mRNA for improved durability, the capacity for rapid development in response to evolving viral strains, and the ability to trigger both antibody and T-cell responses.
In March 2024, Kenvue Inc., a US-based consumer healthcare company, partnered with the Association of Physicians of India (API) to support public health awareness and preventive care efforts. Through this collaboration, Kenvue seeks to improve clinical guidance on hydration and energy management for hospitalized patients with non-diarrheal illnesses. The partnership aims to promote evidence-based recommendations developed jointly with API, a professional organization representing internal medicine physicians in India.
Major players in the norovirus treatment market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, AstraZeneca plc, GSK plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Sun Pharmaceutical Industries Ltd., Lupin Ltd., Aurobindo Pharma Limited, Cipla Inc., and Endo International plc.
North America was the largest region in the norovirus treatment market in 2024. The regions covered in norovirus treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the norovirus treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The norovirus treatment market includes revenues earned by entities by providing services such as symptom management, rehydration therapy, and stool tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The norovirus treatment market also includes sales of oral rehydration solutions (ORS), anti-nausea medications, thermometers, disinfectants, and cleaning products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Norovirus Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on norovirus treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for norovirus treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The norovirus treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Treatment: Electrolytes; Intravenous Fluids; Antipyretics; Analgesics; Anti-Diarrheal; Other Treatments
2) By Diagnosis: Bacteria Culture Test; Stool Tests; Other Diagnosis
3) By Route Of Administration: Oral; Intravenous; Subcutaneous
4) By End User: Hospitals; Clinics; Homecare Settings
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Norovirus Treatment Market Characteristics
3. Norovirus Treatment Market Trends And Strategies
4. Norovirus Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Norovirus Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Norovirus Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Norovirus Treatment Market Growth Rate Analysis
5.4. Global Norovirus Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Norovirus Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Norovirus Treatment Total Addressable Market (TAM)
6. Norovirus Treatment Market Segmentation
6.1. Global Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Electrolytes
Intravenous Fluids
Antipyretics
Analgesics
Anti-Diarrheal
Other Treatments
6.2. Global Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bacteria Culture Test
Stool Tests
Other Diagnosis
6.3. Global Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Subcutaneous
6.4. Global Norovirus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Homecare Settings
6.5. Global Norovirus Treatment Market, Sub-Segmentation Of Electrolytes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Rehydration Salts (ORS)
Sports Drinks
Pediatric Electrolyte Solutions
6.6. Global Norovirus Treatment Market, Sub-Segmentation Of Intravenous Fluids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Crystalloids
Colloids
Lactated Ringer's Solution
6.7. Global Norovirus Treatment Market, Sub-Segmentation Of Antipyretics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acetaminophen (Paracetamol)
Ibuprofen
Aspirin
6.8. Global Norovirus Treatment Market, Sub-Segmentation Of Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Opioid Analgesics
Acetaminophen-Based Analgesics
6.9. Global Norovirus Treatment Market, Sub-Segmentation Of Anti-Diarrheal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Loperamide
Bismuth Subsalicylate
Diphenoxylate-Atropine
6.10. Global Norovirus Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antiemetics
Probiotics
Zinc Supplements
7. Norovirus Treatment Market Regional And Country Analysis
7.1. Global Norovirus Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Norovirus Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Norovirus Treatment Market
9.1. China Norovirus Treatment Market Overview
9.2. China Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Norovirus Treatment Market
10.1. India Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Norovirus Treatment Market
11.1. Japan Norovirus Treatment Market Overview
11.2. Japan Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Norovirus Treatment Market
12.1. Australia Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Norovirus Treatment Market
13.1. Indonesia Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Norovirus Treatment Market
14.1. South Korea Norovirus Treatment Market Overview
14.2. South Korea Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Norovirus Treatment Market
15.1. Western Europe Norovirus Treatment Market Overview
15.2. Western Europe Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Norovirus Treatment Market
16.1. UK Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Norovirus Treatment Market
17.1. Germany Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Norovirus Treatment Market
18.1. France Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Norovirus Treatment Market
19.1. Italy Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Norovirus Treatment Market
20.1. Spain Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Norovirus Treatment Market
21.1. Eastern Europe Norovirus Treatment Market Overview
21.2. Eastern Europe Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Norovirus Treatment Market
22.1. Russia Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Norovirus Treatment Market
23.1. North America Norovirus Treatment Market Overview
23.2. North America Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Norovirus Treatment Market
24.1. USA Norovirus Treatment Market Overview
24.2. USA Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Norovirus Treatment Market
25.1. Canada Norovirus Treatment Market Overview
25.2. Canada Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Norovirus Treatment Market
26.1. South America Norovirus Treatment Market Overview
26.2. South America Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Norovirus Treatment Market
27.1. Brazil Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Norovirus Treatment Market
28.1. Middle East Norovirus Treatment Market Overview
28.2. Middle East Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Norovirus Treatment Market
29.1. Africa Norovirus Treatment Market Overview
29.2. Africa Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Norovirus Treatment Market, Segmentation By Route Of Administration:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Norovirus Treatment Market Competitive Landscape And Company Profiles
